profit from every IDR 100 of sales.
IDR 0IDR 100
PT Enseval Putera Megatrading Tbk.
IDR 2,360.00+2.16% today
+1.3% in 1 year
1-year low IDR 2,230.001-year high IDR 2,660.00
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay IDR 8.10 for every IDR 1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
PT Enseval Putera Megatrading Tbk. vs. similar companies
PT Enseval Putera Megatrading Tbk. grows the slowest of these 5 and is the cheapest for its profits.
| Company | Profit from IDR 100 of sales | Sales growth a year | Price per IDR 1 of profit |
|---|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 8.1× · Cheap | ||
 McKesson | 26.7× · Fair price | ||
 Cencora | 44.1× · Expensive | ||
 Cardinal Health | 41.6× · Expensive | ||
 Sigma Healthcare | 63.0× · Very expensive |
AI analysis
An AI analyst reads PT Enseval Putera Megatrading Tbk.'s last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 8.1×
- –
- –
- 0.8×
- 0.2×
- 10.6×
- –
- 9.4%
- 12.3%
- –
Profitability
- 10.0%
- 3.2%
- 2.4%
- –
- 10.3%
- 10.5%
- –
- –
- –
- –
Growth
- +5.6%
- −2.3%
- –
- –
- +0.0%
Financial health
- -0.6×
- 0.00
- –
- 78.1×
- 2.18
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 30%of 964
Bottom 28%of 898
Top 6%of 651
Bottom 31%of 911
Top 9%of 991
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
64Pass
Benjamin Graham
92Pass
Philip Fisher
36No pass
Peter Lynch
25No pass
Joel Greenblatt
61Pass
Charlie Munger
38No pass
Terry Smith
31No pass
Questions about PT Enseval Putera Megatrading Tbk.
Is PT Enseval Putera Megatrading Tbk. a good stock to buy?
A business with weak numbers, and the price looks low. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the PT Enseval Putera Megatrading Tbk. AI analysis
What does PT Enseval Putera Megatrading Tbk. do?
PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products, consumer products, medical equipment, cosmetics, and other trading products in Indonesia. It is in Medical Distribution.
Is PT Enseval Putera Megatrading Tbk. stock halal?
Yes. PT Enseval Putera Megatrading Tbk. passes our halal screen: its business is permitted and its debt is 0.1% of its market value, under the 30% limit. How we check
How has PT Enseval Putera Megatrading Tbk. stock done over the past year?
Up 1.3% over the past twelve months, to IDR 2,360.00. It traded between IDR 2,230.00 and IDR 2,660.00 and is 11.3% below its high.
Who are PT Enseval Putera Megatrading Tbk.'s competitors?
The largest listed companies in the same industry are McKesson, Cencora, Cardinal Health and Sigma Healthcare. The peers table on this page compares their profit, growth and price with PT Enseval Putera Megatrading Tbk.'s.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.